Literature DB >> 7824184

The influence of plasma glucose concentrations on ischemic brain damage is a threshold function.

P A Li1, M Shamloo, M L Smith, K Katsura, B K Siesjö.   

Abstract

To investigate whether aggravation of damage in hyperglycemic subjects is a continuous function of changes in intra- and extracellular pH during ischemia or whether there is a threshold value, preischemic plasma glucose was varied from 8.3-20.0 mM. 10 min forebrain ischemia was induced. The results showed that no animal with plasma glucose of < 13 mM developed seizures, and that all animals with glucose of > 16 mM died in status epilepticus. Half of the animals with plasma glucose in the range of 13-16 mM showed seizures and 50% of these died. In surviving animals, histological brain damage occurred in the hippocampal CA3 sector, cingulate cortex, thalamic nuclei and substantia nigra, structures normally not injured by 10 min ischemia. The data demonstrate that there is a glucose threshold of 10-13 mM, above which seizures develop and additional damage appears, and another one (> 16 mM), above which seizures are invariably fatal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824184     DOI: 10.1016/0304-3940(94)90045-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Hyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion.

Authors:  Santosh Kumari; Lavita Anderson; Stephanie Farmer; Suresh L Mehta; P Andy Li
Journal:  Transl Stroke Res       Date:  2012-06       Impact factor: 6.829

2.  Reduced expression of IA channels is associated with post-ischemic seizures.

Authors:  Zhigang Lei; Hui Zhang; Yanling Liang; Zao C Xu
Journal:  Epilepsy Res       Date:  2016-05-19       Impact factor: 3.045

3.  Experimental treatment for focal hyperglycemic ischemic brain injury in the rat.

Authors:  Nasim Farrokhnia; Magnus W Roos; Andreas Terént; Fredrik Lennmyr
Journal:  Exp Brain Res       Date:  2005-11-15       Impact factor: 1.972

4.  Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.

Authors:  Ashish K Rehni; Vibha Shukla; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Neuropharmacology       Date:  2018-03-15       Impact factor: 5.250

5.  Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial.

Authors:  Federico Bilotta; Remo Caramia; Ibolja Cernak; Francesca Paola Paoloni; Andrea Doronzio; Vincenzo Cuzzone; Antonio Santoro; Giovanni Rosa
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

6.  Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

Authors:  J Marc Simard; Mingkui Chen; Kirill V Tarasov; Sergei Bhatta; Svetlana Ivanova; Ludmila Melnitchenko; Natalya Tsymbalyuk; G Alexander West; Volodymyr Gerzanich
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

7.  Effect of dexmedetomidine on brain edema and neurological outcomes in surgical brain injury in rats.

Authors:  Michael Benggon; Han Chen; Richard Applegate; Robert Martin; John H Zhang
Journal:  Anesth Analg       Date:  2012-05-14       Impact factor: 5.108

8.  Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.

Authors:  Yilin Zhou; Nancy Fathali; Tim Lekic; Jiping Tang; John H Zhang
Journal:  Brain Res       Date:  2009-03-21       Impact factor: 3.252

9.  Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals Is Associated with Suppressions of mTOR and ERK1/2 Signaling.

Authors:  Ping Liu; Xiao Yang; Changchun Hei; Yvonne Meli; Jianguo Niu; Tao Sun; P Andy Li
Journal:  Int J Biol Sci       Date:  2016-07-18       Impact factor: 6.580

10.  Diabetes inhibits cerebral ischemia-induced astrocyte activation - an observation in the cingulate cortex.

Authors:  Li Jing; Li Mai; Jian-Zhong Zhang; Jian-Gang Wang; Yue Chang; Jian-Da Dong; Feng-Ying Guo; P Andy Li
Journal:  Int J Biol Sci       Date:  2013-09-25       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.